at once through blood tests was a dream. Now new technologies and rigorous clinical trials could put this within our reach" To prevent cancer To address inequities. Noting a plan to ensure that every community in America – rural, urban, Tribal, and everywhere else – has access to cutting-edge cancer diagnostics, therapeutics, and clinical trials. To target the right treatments to the right patients To speed progress against the most deadly and rare cancers, including childhood cancers To support patients, caregivers, and survivors To learn from all patients Re-establish White House Leadership with a White House Cancer Moonshot coordinator in the Executive Office of the President, to demonstrate the President and First Lady's personal commitment to making progress and to leverage the whole-of-government approach and national response that the challenge of cancer demands. And additionally form a Cancer Cabinet, and host a White House Cancer Moonshot Summit. Issue a Call to Action on Cancer Screening and Early Detection. United Kingdom's 2022 National War on Cancer The United Kingdom initiated a 10-year National war on cancer on World Cancer Day on the 4th of February 2022. This was on the same day as United States' 2022 Moonshot 2.0 initiative calling for increasing collaboration for a new front in the war on cancer across countries. It was launched by the Health and Social Care Secretary Sajid Javid at the Francis Crick institute in London. Started in the shadow of the third coronavirus wave in the United Kingdom, Sajid Javid promised the National War on Cancer will "make the UK's cancer care system "the best in Europe"", and "show how we are learning the lessons from the pandemic, and apply them to improving cancer services over the next decade". A set of six new and strengthened priorities were made public including:- Increasing the number of people diagnosed at an early stage where treatment can prove much more effective Intensifying research on new early diagnostic tools to catch cancer at an earlier stage. A key strategy of the National War on Cancer was building on the latest scientific advances and partnering with the country's technology pioneers. The United Kingdom's NHS-Galleri trial is evaluating a new test that looks for distinct markers in blood to identify cancer risk and was listed as a key example of how technology can transform the way cancer is detected. The test is being trialled across England, with thousands of